Behnam Nabet

Behnam Nabet

UNVERIFIED PROFILE

Are you Behnam Nabet?   Register this Author

Register author
Behnam Nabet

Behnam Nabet

Publications by authors named "Behnam Nabet"

Are you Behnam Nabet?   Register this Author

20Publications

827Reads

39Profile Views

Exploring Targeted Degradation Strategy for Oncogenic KRAS.

Cell Chem Biol 2020 Jan 26;27(1):19-31.e6. Epub 2019 Dec 26.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chembiol.2019.12.006DOI Listing
January 2020

Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.

Cell Rep 2019 Oct;29(1):118-134.e8

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.08.090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918830PMC
October 2019

Mutant NPM1 Maintains the Leukemic State through HOX Expression.

Cancer Cell 2018 09;34(3):499-512.e9

Stem Cell and Regenerative Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Texas Children's Hospital and Houston Methodist Hospital, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159911PMC
September 2018

It Takes Two To Target: A Study in KRAS Dimerization.

Biochemistry 2018 04 12;57(16):2289-2290. Epub 2018 Apr 12.

Department of Cancer Biology , Dana-Farber Cancer Institute , Boston , Massachusetts 02215 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.biochem.8b00376DOI Listing
April 2018

YY1 Is a Structural Regulator of Enhancer-Promoter Loops.

Cell 2017 Dec 7;171(7):1573-1588.e28. Epub 2017 Dec 7.

Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785279PMC
December 2017

UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.

Cell Rep 2017 Oct;21(3):628-640

Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Division of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, FL 2033, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.09.078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706555PMC
October 2017

The RNA binding protein RBM38 (RNPC1) regulates splicing during late erythroid differentiation.

PLoS One 2013 18;8(10):e78031. Epub 2013 Oct 18.

Department of Medicine (Hematology-Oncology Division), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078031PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820963PMC
June 2014

Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses.

J Biol Chem 2012 Dec 16;287(50):42352-60. Epub 2012 Oct 16.

Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M112.400721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516778PMC
December 2012

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

Mol Cell 2009 Mar;33(5):591-601

Department of Medicine, Renal Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2009.01.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702247PMC
March 2009

Predictors of prognosis in patients with olfactory disturbance.

Ann Neurol 2008 Feb;63(2):159-66

Department of Otorhinolaryngology: Head and Neck Surgery, Smell and Taste Center, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.21293
Publisher Site
http://dx.doi.org/10.1002/ana.21293DOI Listing
February 2008